Liu F, Xu A, Zhang Y, Xuan W, et al. Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression. Int J Infect Dis 2020 Mar 12. pii: S1201-9712(20)30132.
PMID: 32173576